139 related articles for article (PubMed ID: 34492428)
1. Chemoenzymatic synthesis and biological evaluation of ganglioside GM3 and lyso-GM3 as potential agents for cancer therapy.
Li T; Wang X; Dong P; Yu P; Zhang Y; Meng X
Carbohydr Res; 2021 Nov; 509():108431. PubMed ID: 34492428
[TBL] [Abstract][Full Text] [Related]
2. Streamlined chemoenzymatic total synthesis of prioritized ganglioside cancer antigens.
Yu H; Santra A; Li Y; McArthur JB; Ghosh T; Yang X; Wang PG; Chen X
Org Biomol Chem; 2018 Jun; 16(22):4076-4080. PubMed ID: 29789847
[TBL] [Abstract][Full Text] [Related]
3. Chemoenzymatically synthesized ganglioside GM3 analogues with inhibitory effects on tumor cell growth and migration.
Zheng C; Guan H; Liu Y; Li Z; Bavaro T; Terreni M; Sollogoub M; Xu J; Zhang Y
Eur J Med Chem; 2019 Mar; 165():107-114. PubMed ID: 30665141
[TBL] [Abstract][Full Text] [Related]
4. Effect of lipid mimetics of GM3 and lyso-GM3 dimer on EGF receptor tyrosine kinase and EGF-induced signal transduction.
Haga Y; Hatanaka K; Hakomori SI
Biochim Biophys Acta; 2008 Mar; 1780(3):393-404. PubMed ID: 18036568
[TBL] [Abstract][Full Text] [Related]
5. Preparation of deacetyl-, lyso-, and deacetyl-lyso-GM(3) by selective alkaline hydrolysis of GM3 ganglioside.
Valiente O; Mauri L; Casellato R; Fernandez LE; Sonnino S
J Lipid Res; 2001 Aug; 42(8):1318-24. PubMed ID: 11483634
[TBL] [Abstract][Full Text] [Related]
6. Effect of synthetic sialyl 2-->1 sphingosine and other glycosylsphingosines on the structure and function of the "glycosphingolipid signaling domain (GSD)" in mouse melanoma B16 cells.
Zhang Y; Iwabuchi K; Nunomura S; Hakomori S
Biochemistry; 2000 Mar; 39(10):2459-68. PubMed ID: 10704195
[TBL] [Abstract][Full Text] [Related]
7. The total synthesis of ganglioside GM3.
Duclos RI
Carbohydr Res; 2000 Oct; 328(4):489-507. PubMed ID: 11093705
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of membranes simulating "glycosignaling domain" and their susceptibility to lyso-GM3.
Iwabuchi K; Zhang Y; Handa K; Withers DA; Sinaÿ P; Hakomori S
J Biol Chem; 2000 May; 275(20):15174-81. PubMed ID: 10809752
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of new ganglioside GM3 analogues as potential agents for cancer therapy.
Zheng C; Huang R; Bavaro T; Terreni M; Sollogoub M; Xu J; Zhang Y
Eur J Med Chem; 2020 Mar; 189():112065. PubMed ID: 31978783
[TBL] [Abstract][Full Text] [Related]
10. Chemoenzymatic Total Synthesis of GM3 Gangliosides Containing Different Sialic Acid Forms and Various Fatty Acyl Chains.
Yu H; Gadi MR; Bai Y; Zhang L; Li L; Yin J; Wang PG; Chen X
J Org Chem; 2021 Jul; 86(13):8672-8682. PubMed ID: 34152144
[TBL] [Abstract][Full Text] [Related]
11. Chemoenzymatic Synthesis and Facile Purification of Gangliosides.
Bai Y; Yu H; Chen X
Curr Protoc; 2021 Mar; 1(3):e91. PubMed ID: 33760402
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of lyso-GM3 (II3Neu5Ac Lactosyl sphingosine), de-N-acetyl-GM3 (II3NeuNH2 lactosyl Cer), and related compounds.
Nores GA; Hanai N; Levery SB; Eaton HL; Salyan EK; Hakomori S
Carbohydr Res; 1988 Aug; 179():393-410. PubMed ID: 3208248
[TBL] [Abstract][Full Text] [Related]
13. Enzymic glycosphingolipid synthesis on polymer supports. III. Synthesis of GM3, its analog [NeuNAcalpha(2-3)Galbeta(1-4)Glcbeta(1-3)Cer] and their lyso-derivatives.
Zehavi U; Tuchinsky A
Glycoconj J; 1998 Jul; 15(7):657-62. PubMed ID: 9881771
[TBL] [Abstract][Full Text] [Related]
14. Lyso-GM3, its dimer, and multimer: their synthesis, and their effect on epidermal growth factor-induced receptor tyrosine kinase.
Murozuka Y; Watanabe N; Hatanaka K; Hakomori SI
Glycoconj J; 2007 Dec; 24(9):551-63. PubMed ID: 17638075
[TBL] [Abstract][Full Text] [Related]
15. Chemoenzymatic synthesis of a trimeric ganglioside GM3 analogue.
Earle MA; Manku S; Hultin PG; Li H; Palcic MM
Carbohydr Res; 1997 Jun; 301(1-2):1-4. PubMed ID: 9228735
[TBL] [Abstract][Full Text] [Related]
16. Chemoenzymic synthesis of potentially caged glycosphingolipids [correction of glycoshingolipids] (GSLs): potentially caged lyso-G(M3) and its analogue.
Tuchinsky A; Zehavi U
Chem Phys Lipids; 1998 May; 92(2):91-7. PubMed ID: 9682466
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient chemoenzymatic synthesis and facile purification of α-Gal pentasaccharyl ceramide Galα3nLc
Santra A; Li Y; Yu H; Slack TJ; Wang PG; Chen X
Chem Commun (Camb); 2017 Jul; 53(59):8280-8283. PubMed ID: 28695219
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of ganglioside GM3 derivatives: lyso-GM3, de-N-acetyl-GM3, and other compounds.
Nores GA; Hanai N; Levery SB; Eaton HL; Salyan ME; Hakomori S
Methods Enzymol; 1989; 179():242-53. PubMed ID: 2622350
[No Abstract] [Full Text] [Related]
19. A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth.
Hanai N; Dohi T; Nores GA; Hakomori S
J Biol Chem; 1988 May; 263(13):6296-301. PubMed ID: 2834372
[TBL] [Abstract][Full Text] [Related]
20. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
